Alterola Biotech Financials
| ABTI Stock | USD 0.01 0 25.00% |
Alterola |
Understanding current and past Alterola Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alterola Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Alterola Biotech's assets may result in an increase in income on the income statement.
Alterola Biotech Stock Summary
Alterola Biotech competes with CbdMD, Evolus, Akanda Corp, Biofrontera, and Collegium Pharmaceutical. Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 47 Hamilton Square, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | alterola-abti.com |
| Phone | 44 1516 019 477 |
| Currency | USD - US Dollar |
Alterola Biotech Key Financial Ratios
Alterola Biotech's financial ratios allow both analysts and investors to convert raw data from Alterola Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Alterola Biotech over time and compare it to other companies across industries.| Return On Equity | -1.27 | |||
| Return On Asset | -0.67 | |||
| Beta | -6.65 |
Alterola Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alterola Biotech's current stock value. Our valuation model uses many indicators to compare Alterola Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alterola Biotech competition to find correlations between indicators driving Alterola Biotech's intrinsic value. More Info.Alterola Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Alterola Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Alterola Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Alterola Biotech Systematic Risk
Alterola Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alterola Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Alterola Biotech correlated with the market. If Beta is less than 0 Alterola Biotech generally moves in the opposite direction as compared to the market. If Alterola Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alterola Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alterola Biotech is generally in the same direction as the market. If Beta > 1 Alterola Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Alterola Biotech November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alterola Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alterola Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alterola Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Alterola Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alterola Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 36.94 | |||
| Information Ratio | 0.034 | |||
| Maximum Drawdown | 171.75 | |||
| Value At Risk | (19.00) | |||
| Potential Upside | 25.0 |
Complementary Tools for Alterola Pink Sheet analysis
When running Alterola Biotech's price analysis, check to measure Alterola Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterola Biotech is operating at the current time. Most of Alterola Biotech's value examination focuses on studying past and present price action to predict the probability of Alterola Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterola Biotech's price. Additionally, you may evaluate how the addition of Alterola Biotech to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |